Update 2:40pm: Adds ANI Pharma response, updates shares. Alimera Sciences (NASDAQ:ALIM) pared an earlier drop to 6% after it said it filed a lawsuit against ANI Pharmaceuticals (ANIP) to compel ...
Ani Pharmaceuticals ( (ANIP) ) has released its Q3 earnings. Here is a breakdown of the information Ani Pharmaceuticals presented to its ...
ANIP may be acquired soon with a potential offer exceeding $8 billion and contingent on FDA approval of a new drug filed in ...
the Company completed the acquisition of Alimera Sciences. The transaction significantly expands the scope and scale of ...
ANI is focused on delivering sustainable growth by scaling up ... including statements regarding the benefits of the acquisition of Alimera Sciences. These forward-looking statements generally are ...
During the pandemic lockdowns, iconic folk artist Ani DiFranco was trying to make her 2020 album Revolutionary Love with, for the first time, outside help—in this case, producer and frequent Bon ...
ANI’s Estradiol Gel ... including statements regarding the benefits of the acquisition of Alimera Sciences. These forward-looking statements generally are identified by the words “believe ...
While reporting financial results for the third quarter on Friday, biopharmaceutical company ANI Pharmaceuticals, Inc. (ANIP) raised ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback